home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

Foamy Viruses Join The Gene Therapy Toolbox

  January, 9 2008 23:14
your information resource in human molecular genetics

Foamy virus vectors have been used to cure a genetic immune deficiency in dogs, suggests a paper online in Nature Medicine. The results indicate that they may be useful alternative vectors for curing some diseases by gene therapy.

Foamy viruses are a type of integrating retrovirus found in many mammalian species. Unlike other types of retrovirus used for gene therapy, foamy viruses have never been associated with disease in humans.

Dennis Hickstein and colleagues used a foamy virus vector -- a modified form of the virus that acts as a delivery vehicle for a therapeutic gene - to express the gene for the white blood cell integrin ITGB2 in blood stem cells from dogs with canine leukocyte adhesion deficiency. CLAD dogs normally lack this protein and their immune cells consequently fail to migrate to sites of infection. After reinfusion of the corrected stem cells, the dogs showed complete reversal of disease symptoms, lasting more than two years. The authors also looked at where the foamy virus had integrated into the host cell genome, and found that, compared with gammaretroviral vectors, there was a decreased risk of integration near oncogenes

Author contact:

Dennis Hickstein (National Cancer Institute, Bethesda, MD, USA)
E-mail: hicksted@mail.nih.gov

Abstract available online.

(C) Nature Medicine press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.